All
Research
Education
Business
Solutions
AR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Sign In
Department of Internal Medicine
Cristi King has not added Biography.
If you are Cristi King and would like to personalize this page please email our Author Liaison for assistance.
Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies.
Clinical colorectal cancer Jun, 2004 | Pubmed ID: 15212705
Distribution of ITPA P32T alleles in multiple world populations.
Journal of human genetics , 2004 | Pubmed ID: 15322947
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2004 | Pubmed ID: 15355921
Pyrosequencing of clinically relevant polymorphisms.
Methods in molecular biology (Clifton, N.J.) , 2005 | Pubmed ID: 16100402
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes.
Investigational new drugs Sep, 2006 | Pubmed ID: 16505951
ABCB1 2677G>T/A genotype and paclitaxel pharmacogenetics in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2006 | Pubmed ID: 16818714
Pyrosequencing: a simple method for accurate genotyping.
Methods in molecular biology (Clifton, N.J.) , 2007 | Pubmed ID: 17185756
Identification of NR1I2 genetic variation using resequencing.
European journal of clinical pharmacology Jun, 2007 | Pubmed ID: 17404718
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2007 | Pubmed ID: 17925548
CYP4F2 genetic variant alters required warfarin dose.
Blood Apr, 2008 | Pubmed ID: 18250228
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.
American journal of clinical pathology Jun, 2008 | Pubmed ID: 18480003
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2010 | Pubmed ID: 20530282
Gamma-glutamyl carboxylase and its influence on warfarin dose.
Thrombosis and haemostasis Oct, 2010 | Pubmed ID: 20694283
Washington University in St. Louis
Cristi King1,
Tiffany Scott-Horton1
1Department of Internal Medicine, Washington University in St. Louis
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved
We use cookies to enhance your experience on our website.
By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.
Learn More